Memorandum of Understanding Between the Food and Drug Administration and the Health Products and Food Branch, Health Canada of Canada Regarding Sharing and Exchange of Information about Therapeutic Products

---
identifier: "/us/fr/03-32104"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Memorandum of Understanding Between the Food and Drug Administration and the Health Products and Food Branch, Health Canada of Canada Regarding Sharing and Exchange of Information about Therapeutic Products"
title_number: 0
title_name: "Federal Register"
section_number: "03-32104"
section_name: "Memorandum of Understanding Between the Food and Drug Administration and the Health Products and Food Branch, Health Canada of Canada Regarding Sharing and Exchange of Information about Therapeutic Products"
positive_law: false
currency: "2003-12-31"
last_updated: "2003-12-31"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-32104"
document_type: "notice"
publication_date: "2003-12-31"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "68 FR 75581"
fr_volume: 68
docket_ids:
  - "FDA 225-04-8003"
effective_date: "2003-11-18"
fr_action: "Notice."
---


#  Memorandum of Understanding Between the Food and Drug Administration and the Health Products and Food Branch, Health Canada of Canada Regarding Sharing and Exchange of Information about Therapeutic Products

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration (FDA), Department of Health and Human Services of the United States of America and the Health Products and Food Branch, Health Canada of Canada. The purpose of this MOU is to enhance and strengthen the exchange of information and existing public health protection cooperative activities related to the regulation of the specified therapeutic products.

**DATES:**

The agreement became effective November 18, 2003.

**FOR FURTHER INFORMATION CONTACT:**

Beverly Corey, Office of International Programs ( HFG-1), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-0855.

**SUPPLEMENTARY INFORMATION:**

In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the *Federal Register* , the agency is publishing notice of this MOU.

Dated:  December 17, 2003.

Jeffrey Shuren,

Assistant Commissioner for Policy.